Skip to main content
Premium Trial:

Request an Annual Quote

Helge Bastian, G. Randall Durnell

Helge Bastian has joined Sigma-Aldrich as vice president of global marketing for the Research Biotech unit, the company said this week.
Bastian has more than 15 years of experience in molecular biology and diagnostics, biotechnology, drug development, and the pharmaceutical manufacturing industry. He was previously executive vice president of the life sciences services business unit at SGS. Before that, he was at Qiagen for more than 11 years where he held several management positions, including vice president of molecular diagnostics, vice president of global strategic marketing, and vice president of PreAnalytiX, a joint venture between Qiagen and Becton Dickinson.

Gentel Biosciences this week announced it hired G. Randall Durnell as vice president of commercial operations. Durnell has more than 25 years of corporate and business development in life sciences, Gentel said in a statement, and has worked as an executive at Beckman Coulter, Aurora Biosciences, now part of Vertex Pharmaceuticals, and Pierce Biotechnology, now part of Thermo Fisher Scientific.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.